Influenza and parainfluenza viral infections in children

Pediatr Rev. 2014 Jun;35(6):217-27; quiz 228. doi: 10.1542/pir.35-6-217.

Abstract

• On the basis of strong epidemiologic evidence, influenza and parainfluenza viruses are responsible for significant morbidity and mortality in young infants and children and in persons with chronic medical conditions. (1)(4)(26)(27)(35). • On the basis of research evidence, influenza vaccines are effective in preventing disease in high-risk individuals. (8)(17)(18). • On the basis of strong research evidence, influenza vaccines are safe in young infants and children 6 months or older. (8)(15).• On the basis of research evidence, the use of corticosteroids and epinephrine is beneficial in the treatment of laryngotracheitis caused by parainfluenza viruses. (44)(45)(46)(47). • Strong evidence supports the use of influenza vaccines in pregnant mothers as a strategy to prevent disease in infants younger than 6 months. (17)(18)(19).

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use
  • Child
  • Cross-Sectional Studies
  • Diagnosis, Differential
  • Humans
  • Influenza Vaccines / administration & dosage*
  • Influenza, Human / diagnosis*
  • Influenza, Human / epidemiology
  • Influenza, Human / prevention & control*
  • Parainfluenza Vaccines / administration & dosage*
  • Paramyxoviridae Infections / diagnosis*
  • Paramyxoviridae Infections / epidemiology
  • Paramyxoviridae Infections / prevention & control*

Substances

  • Antiviral Agents
  • Influenza Vaccines
  • Parainfluenza Vaccines